<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-32731" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Cavernous Venous Malformation</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Zyck</surname>
            <given-names>Stephanie</given-names>
          </name>
          <aff>SUNY Upstate Medical University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gould</surname>
            <given-names>Grahame C.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Stephanie Zyck declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Grahame Gould declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>27</day>
          <month>3</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-32731.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Cerebral cavernous malformations, also known as cavernomas or cavernous hemangiomas, are clusters of abnormal and hyalinized capillaries without intervening brain tissue. Due to recurrent microhemorrhages and thrombosis, they are typically surrounded by hemosiderin deposits and gliosis. These lesions have slow flow and low pressure, causing average rupture risk to be much lower than that of some other vascular malformations such as arteriovenous malformations. Rupture risk is also dependent on the cavernoma's location, presence of associated developmental venous anomaly, and gender. Asymptomatic familial cases are also thought to have a higher annual hemorrhage rate than asymptomatic sporadic cases. Cavernous malformations may also arise de novo. They may grow, shrink, or remain stable over time. This activity reviews the evaluation of cavernous venous malformations and identifies the role of the interprofessional team in managing this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review the pathophysiology of cerebral cavernous malformations.</p></list-item><list-item><p>Describe the workup of a patient with cerebral cavernous malformations.</p></list-item><list-item><p>Summarize the treatment options for cerebral cavernous malformations.</p></list-item><list-item><p>Outline the evaluation of cavernous venous malformations and identify the role of the interprofessional team in managing this condition.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=32731&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=32731">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-32731.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Cerebral cavernous malformations, also known as cavernomas or cavernous hemangiomas, are clusters of abnormal and hyalinized capillaries without&#x000a0;intervening&#x000a0;brain tissue (see <bold>Images.</bold>&#x000a0;Pons Cavernoma, Head CT, Cavernous Malformation).&#x000a0;Due to recurrent microhemorrhages and thrombosis, they&#x000a0;are&#x000a0;typically surrounded by hemosiderin deposits and gliosis. These lesions have slow flow and low pressure, causing the average rupture risk to be much lower than that of some other vascular malformations, such as arteriovenous malformations. Cavernomas are often found incidentally, but can also present during evaluation of headaches, seizures, focal neurologic deficits, or symptomatic hemorrhage.<xref ref-type="bibr" rid="article-32731.r1">[1]</xref>&#x000a0;</p>
        <p>aSupratentorial location is the most common, though lesions in the basal ganglia, brainstem, cerebellum, and spine also can occur. They can be associated with developmental venous anomalies (DVAs).<xref ref-type="bibr" rid="article-32731.r2">[2]</xref></p>
        <p>The average annual&#x000a0;rate of hemorrhage is&#x000a0;reported at&#x000a0;0.7%-1.1% per lesion in patients without a history of prior hemorrhage.<xref ref-type="bibr" rid="article-32731.r3">[3]</xref> This risk rises to approximately 4.5% in patients who have sustained previous intracerebral hemorrhage.<xref ref-type="bibr" rid="article-32731.r3">[3]</xref> Approximately 2-3 years after a hemorrhagic event, the risk of hemorrhage is thought to decrease.&#x000a0;Rupture risk is also dependent on the cavernoma's location, presence of associated developmental venous anomaly, and gender.<xref ref-type="bibr" rid="article-32731.r4">[4]</xref> Infratentorial location, deep location, young age, and female gender are associated with increased risk.<xref ref-type="bibr" rid="article-32731.r3">[3]</xref>,<xref ref-type="bibr" rid="article-32731.r2">[2]</xref>&#x000a0;Asymptomatic familial cases are also thought to have a higher annual hemorrhage rate than asymptomatic sporadic cases.<xref ref-type="bibr" rid="article-32731.r2">[2]</xref>&#x000a0;Cavernous malformations may also arise de novo.<xref ref-type="bibr" rid="article-32731.r5">[5]</xref> They may grow, shrink, or remain stable&#x000a0;over time.<xref ref-type="bibr" rid="article-32731.r6">[6]</xref></p>
      </sec>
      <sec id="article-32731.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Cavernomas can be seen in either familial or sporadic cases. Between 40% to 60% of cases are familial.<xref ref-type="bibr" rid="article-32731.r1">[1]</xref> Sporadic cases tend to&#x000a0;present with a single cavernoma;&#x000a0;familial cases tend to&#x000a0;present with multiple cavernous malformations. In&#x000a0;familial cases, an autosomal dominant mutation is usually the culprit in the <italic toggle="yes">CCM1</italic>/<italic toggle="yes">KRIT1, CCM2</italic>/<italic toggle="yes">Malcavernin</italic>, and <italic toggle="yes">CCM3</italic>/<italic toggle="yes">PDCD10</italic>&#x000a0;genes located respectfully on the 7q, 7p, and 3p chromosomes.<xref ref-type="bibr" rid="article-32731.r3">[3]</xref><xref ref-type="bibr" rid="article-32731.r7">[7]</xref>&#x000a0;Those expressed genes encoded by the <italic toggle="yes">CCM</italic> genes interact in neural tissue with capillary endothelial tight junctions&#x000a0;and&#x000a0;cytoskeletal proteins&#x000a0;during angiogenesis.<xref ref-type="bibr" rid="article-32731.r1">[1]</xref>&#x000a0;A&#x000a0;common deletion in <italic toggle="yes">CCM2 </italic>was found to be responsible&#x000a0;for clustering among Ashkenazi Jews.<xref ref-type="bibr" rid="article-32731.r8">[8]</xref></p>
        <p>Recently, genetic studies on the surgically-resected lesions from sporadic cases lacking inherited germline mutations have shown somatic mutations of the same three <italic toggle="yes">CCM</italic> genes. This could point towards identical molecular mechanisms&#x000a0;in both familial and sporadic cavernomas.<xref ref-type="bibr" rid="article-32731.r9">[9]</xref></p>
      </sec>
      <sec id="article-32731.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The incidence of cavernomas is approximately&#x000a0;0.4% to 0.8% in the general population.<xref ref-type="bibr" rid="article-32731.r3">[3]</xref> Though uncommon, they are the most common&#x000a0;cerebral vascular&#x000a0;abnormality and account for 10% to 25% of all vascular malformations.<xref ref-type="bibr" rid="article-32731.r3">[3]</xref>&#x000a0;There is no gender predilection.<xref ref-type="bibr" rid="article-32731.r10">[10]</xref> They occur in both adults and children, though the mean patient age is in the fourth decade.<xref ref-type="bibr" rid="article-32731.r1">[1]</xref> The&#x000a0;proportion of familial cases of&#x000a0;cavernous malformations is reported to be higher in Hispanic-American populations compared with other populations, with rates as high as 50%.<xref ref-type="bibr" rid="article-32731.r7">[7]</xref></p>
      </sec>
      <sec id="article-32731.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Mutations in the cavernoma genes can cause activation of downstream Rho-A kinase (ROCK), which causes endothelial barrier dysfunction. Cavernomas&#x000a0;typically most often during the 2nd to 5th decades of life&#x000a0;with&#x000a0;seizures (50%), symptomatic hemorrhage (25%), and focal neurological deficits without radiographic evidence of recent hemorrhage (25%).<xref ref-type="bibr" rid="article-32731.r11">[11]</xref>&#x000a0;Around 20%&#x02013;50% of patients can have an incidentally detected cavernoma.&#x000a0;The risk of first symptomatic hemorrhage has been found to be extremely low (0.08% per patient-year) in the latter population.&#x000a0;However, once symptomatic hemorrhage has happened, there is an annual 10-fold increased risk of a subsequent episode of bleeding.&#x000a0;This increased&#x000a0;risk is highest&#x000a0;soon after a hemorrhage but continues&#x000a0;thereafter, with a 5-year risk estimated at 42%. Brainstem lesions and&#x000a0;CCM3 familial cases with <italic toggle="yes">PDCD10/CCM3</italic> mutations are associated with a greater risk of bleeding. Cavernous angiomas&#x000a0;with symptomatic hemorrhage (CASH) include lesions that impact a patient&#x02019;s life and merit clinical intervention.</p>
      </sec>
      <sec id="article-32731.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>On histological examination, cavernomas are seen as abnormally dilated and hyalinized capillaries (caverns) without intervening brain tissue. Gliosis and hemosiderin deposits are seen along the margins. Gross pathological appearance is often described as a "mulberry." Light microscopy shows an absence of a smooth muscle wall layer and electron microscopy shows abnormalities in endothelial gap junctions.<xref ref-type="bibr" rid="article-32731.r12">[12]</xref></p>
      </sec>
      <sec id="article-32731.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Cavernomas can present with headaches, focal neurologic deficits, seizures, hemorrhage, or incidental findings. A review by Ene and colleagues found that the most common presentation of cavernous malformations was seizures at an average of 40.6% of cavernoma cases.<xref ref-type="bibr" rid="article-32731.r2">[2]</xref> Symptomatic hemorrhage has been reported in between 0.7% to 6.5% of cases, although exact rates vary in the literature.<xref ref-type="bibr" rid="article-32731.r2">[2]</xref> A meta-analysis by Washington and colleagues found the most common presentation to be seizures for supratentorial lesions and focal neurologic deficits or ataxia for infratentorial lesions.<xref ref-type="bibr" rid="article-32731.r10">[10]</xref> The proportion of cavernomas that were incidentally diagnosed&#x000a0;during an evaluation for unrelated symptoms (headache, for example)&#x000a0;has been reported between 6%&#x000a0;and&#x000a0;65%.<xref ref-type="bibr" rid="article-32731.r1">[1]</xref>&#x000a0;This amount has likely increased over time due to the increasing availability and utilization&#x000a0;of magnetic resonance imaging (MRI).<xref ref-type="bibr" rid="article-32731.r10">[10]</xref>&#x000a0;History and physical examination of a patient with a newly diagnosed cavernoma&#x000a0;should include a thorough review of prior neurologic events, review of any antithrombotic medications, seizure history, detailed neurologic exam, and 3-generation family history, particularly concerning vascular malformations.<xref ref-type="bibr" rid="article-32731.r13">[13]</xref></p>
      </sec>
      <sec id="article-32731.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Cavernomas&#x000a0;can be&#x000a0;more difficult to diagnose than other vascular malformations because of their low flow state and small size of the abnormal blood vessels. In particular, cerebral angiography is insensitive for the detection of these lesions, giving rise to the term "angiographically occult".</p>
        <p>On computed tomography (CT)&#x000a0;imaging, cavernomas may appear well demarcated with either a homogeneous or heterogeneous high density related to calcification, thrombosis, increased blood volume, and hemosiderin deposition.&#x000a0;They may&#x000a0;demonstrate some&#x000a0;degree of&#x000a0;contrast enhancement. Significant edema or mass effect is unusual except in cases with recent hemorrhage.<xref ref-type="bibr" rid="article-32731.r14">[14]</xref>&#x000a0;CT lacks both sensitivity and specificity for cavernous malformations. It should not be the&#x000a0;primary imaging study performed in these cases due to&#x000a0;the high&#x000a0;probability&#x000a0;of missing or misdiagnosing lesions.</p>
        <p>Magnetic resonance imaging (MRI) is the diagnostic modality of choice, particularly gradient-echo sequences (T2*/GRE) showing the "blooming effect of hemosiderin" and susceptibility-weighted imaging sequences (SWI/VenBold) that&#x000a0;show areas of prior hemorrhage and multifocal lesions when done at 3T. There are usually&#x000a0;mixed signals of blood at different stages of organization and calcifications, with a surrounding hemosiderin ring&#x000a0;(best appreciated on T2-weighted sequences).</p>
        <p>Cavernous malformations can be divided into four groups (Zabramski classification) based on their appearance on MRI (see <bold>Image.</bold> Cavernoma,&#x000a0;Zabramski&#x000a0;Classification).<xref ref-type="bibr" rid="article-32731.r15">[15]</xref>&#x000a0;Type I lesions appear hyperintense on both T1- and T2-weighted sequences due to their subacute hemorrhage and hemosiderin core. Type II lesions&#x000a0;represent the&#x000a0;classic "popcorn" lesions often described. These type II lesions have mixed signal intensity on both T1 and T2 sequences due to multiple loculated hemorrhages of various stages enclosed by gliotic margins. For these lesions,&#x000a0;the gliotic peripheral rim demonstrates decreased signal intensity on T2 sequences.&#x000a0;Type III lesions&#x000a0;demonstrate chronic resolved hemorrhage within an isointense core. Type IV&#x000a0;lesions are&#x000a0;thought to represent&#x000a0;small&#x000a0;capillary telangiectasias that&#x000a0;can only be seen on gradient resonance echo sequences. Some authors report an increased risk of hemorrhage for Type 1 and type 2 lesions, prompting consideration for more aggressive surgical management for these types.<xref ref-type="bibr" rid="article-32731.r1">[1]</xref><xref ref-type="bibr" rid="article-32731.r15">[15]</xref>&#x000a0;Diffusion tensor sequences and functional MRI (fMRI) can be useful for surgical planning by visualizing white matter tracts and eloquent areas.<xref ref-type="bibr" rid="article-32731.r3">[3]</xref>,<xref ref-type="bibr" rid="article-32731.r1">[1]</xref>&#x000a0;Presence of an associated developmental venous anomaly on imaging&#x000a0;should also be noted due to implications for hemorrhage risk and surgical technique. If several cavernomas surround the periphery of a single developmental venous anomaly, then this is considered part of a single vascular complex consistent with sporadic (versus familial) occurrence.<xref ref-type="bibr" rid="article-32731.r13">[13]</xref></p>
        <p>New MRI techniques - quantitative susceptibility mapping (QSM) and dynamic contrast-enhanced quantitative perfusion (DCEQP) - can&#x000a0;measure the quantity of iron deposition and vascular permeability in cavernomas and can be&#x000a0;potential biomarkers of disease activity.<xref ref-type="bibr" rid="article-32731.r16">[16]</xref></p>
      </sec>
      <sec id="article-32731.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Conservative management with serial imaging and observation, microsurgical resection, and stereotactic radiosurgery are the 3 main options for the management of cerebral cavernomas. When&#x000a0;discussing treatment options, the risks of intervention versus the risks of having an untreated cavernous malformation must be weighed carefully. The natural history of cavernous malformations, clinical presentation, lesion location, number of hemorrhagic events, and medical comorbidities help guide this discussion.<xref ref-type="bibr" rid="article-32731.r17">[17]</xref>&#x000a0;For small and incidentally discovered lesions, observation is often reasonable.<xref ref-type="bibr" rid="article-32731.r17">[17]</xref></p>
        <p>According to the Cerebral Cavernous Malformations Care Guidelines published in 2017 by the Angioma Alliance (https://www.angioma.org/for-professionals/clinicians/ccm-care-guidelines), surgical resection is not recommended for asymptomatic cavernous malformations. This is particularly&#x000a0;true for multiple lesions or situations in which the lesions are located in deep, eloquent, or brainstem tissue. Surgical resection may be considered for a solitary asymptomatic cavernous malformation if the lesion&#x000a0;is in a non-eloquent&#x000a0;and accessible location. In those cases, the benefits to resection&#x000a0;may include prevention of hemorrhage, reduction of time and costs of follow-up, relief of psychological burden,&#x000a0;lifestyle or career decisions, or&#x000a0;facilitation of future&#x000a0;anti-coagulation if needed.<xref ref-type="bibr" rid="article-32731.r13">[13]</xref></p>
        <p>As per those same guidelines, early surgical resection should be considered for medically refractory epilepsy&#x000a0;when the epileptogenic focus is&#x000a0;related to the&#x000a0;cavernoma. Such early intervention may prevent a "kindling" effect and&#x000a0;improve the likelihood of seizure freedom.&#x000a0;For symptomatic and&#x000a0;easily accessible cavernous hemangiomas, it has been suggested that morbidity and mortality associated with surgery are approximately equivalent to the risk of living with a cavernoma for 2 years. For symptomatic&#x000a0;and deeply located&#x000a0;cavernomas, morbidity and mortality associated with surgical resection may be considered&#x000a0;to be&#x000a0;approximately&#x000a0;equivalent to living with the cavernoma for 5 to 10 years. While surgery is not typically recommended for brainstem cavernomas due to a significant risk of complications, many recommend operating after a second symptomatic bleed due to the concept that those cavernomas may have a more aggressive natural course. Indications for resection of brainstem cavernomas after a single disabling hemorrhage or spinal cavernomas are more controversial.<xref ref-type="bibr" rid="article-32731.r13">[13]</xref></p>
        <p>For cases undergoing surgical resection, steroids&#x000a0;may be considered 1 to 2 weeks before&#x000a0;surgery to reduce edema and aid with resection. Resection of any associated developmental venous anomalies should be strictly avoided due to potential venous infarction. Complete removal of the lesion is required to prevent recurrent hemorrhages. If the surgery is being performed for seizures, the hemosiderin-stained surrounding neural parenchyma and gliosis should also be resected when feasible. After surgery, MRI within 72 hours is recommended to ensure complete resection.&#x000a0;Some authors report a 40% risk of rebleeding of cavernoma remnants after partial resection.<xref ref-type="bibr" rid="article-32731.r3">[3]</xref></p>
        <p>Stereotactic radiosurgery has been proposed as an alternative to microsurgery for treatment, although the effect of radiosurgery on reducing risks of re-bleeding remains controversial. Even for proponents of the technique, radiosurgery is thought to have&#x000a0;a 2-year latency period before optimal risk reduction of recurrent hemorrhage occurs. While microsurgical resection remains the standard treatment for cavernomas, stereotactic radiosurgery is an option for solitary symptomatic lesions with an unacceptably high surgical risk.<xref ref-type="bibr" rid="article-32731.r3">[3]</xref><xref ref-type="bibr" rid="article-32731.r13">[13]</xref>&#x000a0;In general, it is not recommended for cavernous malformations that are asymptomatic, surgically accessible, or familial due to the risk of de novo cavernoma formation.<xref ref-type="bibr" rid="article-32731.r13">[13]</xref></p>
        <p>For patients with a newly diagnosed cerebral cavernoma and with no history of brain radiation, no positive family history, or multiple cavernous malformations, genetic testing should be considered. If a positive mutation is found, genetic counseling should be offered to the patient and family.<xref ref-type="bibr" rid="article-32731.r13">[13]</xref> First-degree relatives of patients with more than one family member with a cavernoma should also have a screening MRI recommended as well as genetic counseling.</p>
        <p>Medical treatment (still in trial stage) with ROCK inhibitor, statins (with multiple&#x000a0;effects including Rho inhibition), vitamin D, and B-cell depletion has shown to decrease hemorrhage in&#x000a0;cavernomas.<xref ref-type="bibr" rid="article-32731.r18">[18]</xref></p>
      </sec>
      <sec id="article-32731.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differential diagnosis may include other&#x000a0;cerebral vascular malformations&#x000a0;such as arteriovenous malformations, venous angiomas, capillary telangiectasias, dural arteriovenous fistulas, aneurysm, and vein of Galen malformations. MRI is the best study to diagnose cerebral cavernous malformations due to characteristic imaging findings, although angiography for the&#x000a0;exclusion&#x000a0;of other cerebrovascular pathologies under consideration may be helpful in certain clinical settings (such as spontaneous&#x000a0;intracranial hemorrhage).</p>
      </sec>
      <sec id="article-32731.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Prognosis depends on the location of the bleed and the degree of neurological deficits.</p>
      </sec>
      <sec id="article-32731.s12" sec-type="Complications">
        <title>Complications</title>
        <p>The main complications associated with cavernomas include intracerebral hemorrhage, neurological deficits, seizures, and rarely a risk to life.</p>
      </sec>
      <sec id="article-32731.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>Neurosurgery consultation is recommended for the management of patients with a cerebral or spinal cavernous malformation.</p>
      </sec>
      <sec id="article-32731.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Some activities might have to be restricted for people with cavernomas (not proven), which include mountain climbing above 10000 feet, smoking, water activities, and contact sports. Most studies suggest that the use of antiplatelet medications (for other conditions, if needed) is safe in these patients.</p>
      </sec>
      <sec id="article-32731.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>MRI is the standard imaging modality&#x000a0;for the diagnosis of cavernous malformations. Cerebral angiography is typically not indicated unless exclusion of other cerebrovascular pathology is being considered.</p>
        <list list-type="bullet">
          <list-item>
            <p>For an initial seizure thought to be related to a cavernoma, anti-epileptic medication&#x000a0;is a reasonable first-line therapy&#x000a0;(Class I, Level B). Surgical resection should be considered for medically refractory epilepsy&#x000a0;when the&#x000a0;epileptogenic focus is related to a cavernoma.<xref ref-type="bibr" rid="article-32731.r13">[13]</xref></p>
          </list-item>
          <list-item>
            <p>Genetic counseling should be considered for those with familial or multiple cavernomas (Class I, Level C).<xref ref-type="bibr" rid="article-32731.r13">[13]</xref></p>
          </list-item>
          <list-item>
            <p>Neurosurgical consultation is indicated for the management of cavernous malformations. Treatment options include observation with serial imaging, surgical resection, and stereotactic radiosurgery.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-32731.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=32731&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=32731">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/cavernous-venous-malformation/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=32731">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/32731/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=32731">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-32731.s17">
        <fig id="article-32731.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Pons Cavernoma,&#x000a0;Head CT Contributed by S Dulebohn, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pons__cavernoma" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-32731.s18">
        <fig id="article-32731.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Cavernoma, Zabramski Classification. Magnetic resonance imaging depicts a cavernous malformation in the left middle cerebellar peduncle of a patient who presented with right-sided facial numbness and ataxia. Varying signal intensities on T1&#x02014;and T2-weighted sequences and blood detection on susceptibility-weighted sequences (left, middle, and right images, respectively) characteristic of a cavernoma are seen. Imaging findings are consistent with a Zabramski type 2 cavernoma with mixed signal intensities on both type 1 and type 2, giving it a "popcorn-like" appearance. Contributed by G Gould, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Cavernoma" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-32731.s19">
        <fig id="article-32731.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Cavernous Malformation. The top three images show magnetic resonance imaging depicting a cavernous malformation in the left middle cerebellar peduncle of a 42-year-old woman who presented with right-sided facial numbness and ataxia. Varying signal intensities on T1- and T2-weighted sequences and blood detection on susceptibility-weighted sequences (left, middle, and right images, respectively) characteristic of a cavernoma are seen. The bottom image &#x02014; a weighted image with contrast enhancement &#x02014; shows&#x000a0;a large developmental venous anomaly (DVA) that is associated with the adjacent cavernous malformation. Contributed by G Gould, MD, and S Zyck, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Cavernous_Malformation_Cavernoma_and_DVA" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-32731.s20">
        <title>References</title>
        <ref id="article-32731.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dalyai</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Ghobrial</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Awad</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Tjoumakaris</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gonzalez</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Dumont</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Chalouhi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Randazzo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rosenwasser</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jabbour</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Management of incidental cavernous malformations: a review.</article-title>
            <source>Neurosurg Focus</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>31</volume>
            <issue>6</issue>
            <fpage>E5</fpage>
            <pub-id pub-id-type="pmid">22133177</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32731.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ene</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kaul</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Natural history of cerebral cavernous malformations.</article-title>
            <source>Handb Clin Neurol</source>
            <year>2017</year>
            <volume>143</volume>
            <fpage>227</fpage>
            <page-range>227-232</page-range>
            <pub-id pub-id-type="pmid">28552144</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32731.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mouchtouris</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Chalouhi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Chitale</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Starke</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Tjoumakaris</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Rosenwasser</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Jabbour</surname>
                <given-names>PM</given-names>
              </name>
            </person-group>
            <article-title>Management of cerebral cavernous malformations: from diagnosis to treatment.</article-title>
            <source>ScientificWorldJournal</source>
            <year>2015</year>
            <volume>2015</volume>
            <fpage>808314</fpage>
            <pub-id pub-id-type="pmid">25629087</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32731.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wurm</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Schnizer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fellner</surname>
                <given-names>FA</given-names>
              </name>
            </person-group>
            <article-title>Cerebral cavernous malformations associated with venous anomalies: surgical considerations.</article-title>
            <source>Neurosurgery</source>
            <year>2005</year>
            <month>Jul</month>
            <volume>57</volume>
            <issue>1 Suppl</issue>
            <fpage>42</fpage>
            <page-range>42-58; discussion 42-58</page-range>
            <pub-id pub-id-type="pmid">15987569</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32731.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Massa-Micon</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Luparello</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bergui</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pagni</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>De novo cavernoma case report and review of literature.</article-title>
            <source>Surg Neurol</source>
            <year>2000</year>
            <month>May</month>
            <volume>53</volume>
            <issue>5</issue>
            <fpage>484</fpage>
            <page-range>484-7</page-range>
            <pub-id pub-id-type="pmid">10874148</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32731.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clatterbuck</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Moriarity</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Elmaci</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Breiter</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Rigamonti</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Dynamic nature of cavernous malformations: a prospective magnetic resonance imaging study with volumetric analysis.</article-title>
            <source>J Neurosurg</source>
            <year>2000</year>
            <month>Dec</month>
            <volume>93</volume>
            <issue>6</issue>
            <fpage>981</fpage>
            <page-range>981-6</page-range>
            <pub-id pub-id-type="pmid">11117871</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32731.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Introduction to cerebral cavernous malformation: a brief review.</article-title>
            <source>BMB Rep</source>
            <year>2016</year>
            <month>May</month>
            <volume>49</volume>
            <issue>5</issue>
            <fpage>255</fpage>
            <page-range>255-62</page-range>
            <pub-id pub-id-type="pmid">26923303</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32731.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gallione</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Solatycki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Awad</surname>
                <given-names>IA</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Marchuk</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>A founder mutation in the Ashkenazi Jewish population affecting messenger RNA splicing of the CCM2 gene causes cerebral cavernous malformations.</article-title>
            <source>Genet Med</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>13</volume>
            <issue>7</issue>
            <fpage>662</fpage>
            <page-range>662-6</page-range>
            <pub-id pub-id-type="pmid">21543988</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32731.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McDonald</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Shenkar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gallione</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Akers</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>De Castro</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Berg</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Corcoran</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Awad</surname>
                <given-names>IA</given-names>
              </name>
              <name>
                <surname>Marchuk</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis.</article-title>
            <source>Hum Mol Genet</source>
            <year>2014</year>
            <month>Aug</month>
            <day>15</day>
            <volume>23</volume>
            <issue>16</issue>
            <fpage>4357</fpage>
            <page-range>4357-70</page-range>
            <pub-id pub-id-type="pmid">24698976</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32731.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Washington</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>McCoy</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Zipfel</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Update on the natural history of cavernous malformations and factors predicting aggressive clinical presentation.</article-title>
            <source>Neurosurg Focus</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>E7</fpage>
            <pub-id pub-id-type="pmid">20809765</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32731.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al-Shahi Salman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Horne</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Moultrie</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Josephson</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Bhattacharya</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Counsell</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Papanastassiou</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ritchie</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Sellar</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Warlow</surname>
                <given-names>CP</given-names>
              </name>
              <collab>Scottish Audit of Intracranial Vascular Malformations (SAIVMs) collaborators</collab>
            </person-group>
            <article-title>Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study.</article-title>
            <source>Lancet Neurol</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>217</fpage>
            <page-range>217-24</page-range>
            <pub-id pub-id-type="pmid">22297119</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32731.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wong</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Awad</surname>
                <given-names>IA</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Ultrastructural pathological features of cerebrovascular malformations: a preliminary report.</article-title>
            <source>Neurosurgery</source>
            <year>2000</year>
            <month>Jun</month>
            <volume>46</volume>
            <issue>6</issue>
            <fpage>1454</fpage>
            <page-range>1454-9</page-range>
            <pub-id pub-id-type="pmid">10834648</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32731.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Akers</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Al-Shahi Salman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>A Awad</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Dahlem</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Flemming</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hart</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Jusue-Torres</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Kondziolka</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Morrison</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rigamonti</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rebeiz</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tournier-Lasserve</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Waggoner</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Whitehead</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel.</article-title>
            <source>Neurosurgery</source>
            <year>2017</year>
            <month>May</month>
            <day>01</day>
            <volume>80</volume>
            <issue>5</issue>
            <fpage>665</fpage>
            <page-range>665-680</page-range>
            <pub-id pub-id-type="pmid">28387823</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32731.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bitoh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hasegawa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fujiwara</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sakurai</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Angiographically occult vascular malformations causing intracranial hemorrhage.</article-title>
            <source>Surg Neurol</source>
            <year>1982</year>
            <month>Jan</month>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>35</fpage>
            <page-range>35-42</page-range>
            <pub-id pub-id-type="pmid">7071717</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32731.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zabramski</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Wascher</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Spetzler</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Golfinos</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Drayer</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rigamonti</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>The natural history of familial cavernous malformations: results of an ongoing study.</article-title>
            <source>J Neurosurg</source>
            <year>1994</year>
            <month>Mar</month>
            <volume>80</volume>
            <issue>3</issue>
            <fpage>422</fpage>
            <page-range>422-32</page-range>
            <pub-id pub-id-type="pmid">8113854</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32731.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mikati</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Shenkar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Larsson</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Edelman</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Christoforidis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Awad</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Dynamic permeability and quantitative susceptibility: related imaging biomarkers in cerebral cavernous malformations.</article-title>
            <source>Stroke</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>45</volume>
            <issue>2</issue>
            <fpage>598</fpage>
            <page-range>598-601</page-range>
            <pub-id pub-id-type="pmid">24302484</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32731.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Atwal</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Sarris</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Spetzler</surname>
                <given-names>RF</given-names>
              </name>
            </person-group>
            <article-title>Brainstem and cerebellar cavernous malformations.</article-title>
            <source>Handb Clin Neurol</source>
            <year>2017</year>
            <volume>143</volume>
            <fpage>291</fpage>
            <page-range>291-295</page-range>
            <pub-id pub-id-type="pmid">28552152</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32731.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Awad</surname>
                <given-names>IA</given-names>
              </name>
              <name>
                <surname>Polster</surname>
                <given-names>SP</given-names>
              </name>
            </person-group>
            <article-title>Cavernous angiomas: deconstructing a neurosurgical disease.</article-title>
            <source>J Neurosurg</source>
            <year>2019</year>
            <month>Jul</month>
            <day>01</day>
            <volume>131</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-13</page-range>
            <pub-id pub-id-type="pmid">31261134</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
